Washington, D.C. – The Campaign for Personal Prescription Importation (CPPI) predicts that drug price hikes in 2021 will drive increased prescription importation. Some 735 drugs have seen price increases in January 2021. Reports from healthcare research firm 3 Axis Advisors and announcements by drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc, show plans for drug price hikes by as much as 10 percent in 2021.
Leave a Reply